Order through miCheckup
Review current eligibility, availability, pricing and important information on the dedicated product website before reserving the test.
Oncology application · How it works
From one blood sample to a physician-reviewed next step.
miCheckup turns miRoncol’s microRNA research into a defined testing pathway: order the test, provide a routine blood sample, have the sample analyzed and receive results with physician guidance.
This miRoncol page explains the relationship between the test and the platform. Current availability, pricing, collection locations and product instructions remain on miCheckup.
CollectionOne routine blood draw
PreparationNo fasting currently required
AnalysisPerformed in an accredited Canadian laboratory
ResultsReviewed with a physician
The current test journey
A defined process from order to clinical context.
The product workflow is intentionally straightforward. The complex molecular work happens behind the scenes; the customer sees four understandable steps and a supported result.
Provide a standard blood sample
Book at a participating collection centre. The current miCheckup process describes a routine blood draw of approximately ten minutes with no fasting required.
Your microRNA pattern is analyzed
The sample is processed in Canada. The analysis evaluates disease-associated patterns within the circulating microRNA profile for the test’s oncology application.
Review the result with a physician
The current service states that results are returned in approximately four to eight weeks and reviewed with a physician, including the appropriate next step for either result category.
Product timing, locations and service inclusions can change. Confirm the current process directly on miCheckup’s How It Works page ↗.
Inside the analytical layer
The sample is simple. The interpretation is not.
A useful oncology result depends on reliable measurement, a defined analytical model and clinical interpretation,not simply detecting one molecule.
Circulating microRNAs
Analyze a panel of small regulatory molecules found in the blood rather than a single biomarker in isolation.
Multivariable patterns
Apply the validated analytical approach behind the oncology application to evaluate relationships across the measured signals.
Clinical context
Place the laboratory result within a physician-guided pathway that recognizes limitations and defines appropriate follow-up.
Understanding the result
Two result categories. Neither is a diagnosis.
The result communicates whether the measured profile contains a pattern that warrants further investigation. It does not determine whether cancer is present or absent.
Reassuring information,with limits.
The analysis did not identify the disease-associated pattern targeted by the test at that time. This does not rule out cancer or replace recommended screening.
Next step: continue recommended screening and seek care for new symptoms.A reason to investigate,not a diagnosis.
The measured profile contains a pattern that warrants further evaluation. The current miCheckup service includes physician guidance and a whole-body MRI at no additional cost.
Next step: physician-led imaging and appropriate clinical follow-up.False-positive and false-negative results can occur. Many findings identified through further investigation may be benign. A cancer diagnosis requires confirmatory diagnostic evaluation through established medical procedures.
Responsible use
Early information must come with clear boundaries.
The test is designed to add a layer of screening information. It is not designed to replace symptoms, established screening or medical judgment.
Not for diagnosing symptoms
If you are experiencing symptoms that may indicate cancer, seek medical attention rather than relying on an early-detection screening test.
Continue established screening
Continue mammography, Pap/HPV testing, colorectal screening and other programs recommended by your healthcare provider.
Both result categories have limitations
A negative result does not eliminate risk, while a positive signal does not establish that cancer is present.
Use current product information
Eligibility, availability, contraindications, regulatory information and service inclusions should be confirmed on miCheckup before ordering.
Two websites, two jobs
The company explains the platform. The product explains the test.
Stay on miRoncol for the broader intelligence story.
Explore microRNA science, longitudinal data, AI-assisted interpretation, research directions and the company building the platform.
Explore the platform
Go to miCheckup for current testing information.
Review eligibility, availability, pricing, collection, results, MRI follow-up and the complete important information.
See how the test worksCurrent product journey
Ready to understand the miCheckup process?
The dedicated test website contains the latest ordering steps, availability, pricing and complete safety and regulatory information.